Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension
Phase 1
Completed
- Conditions
- Glaucoma and Ocular Hypertension
- Interventions
- Drug: Vehicle
- First Posted Date
- 2012-09-19
- Last Posted Date
- 2012-12-25
- Lead Sponsor
- Eye Therapies, LLC
- Target Recruit Count
- 15
- Registration Number
- NCT01687426
- Locations
- 🇺🇸
Clinical Site, Winchester, Massachusetts, United States
Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects
- First Posted Date
- 2012-08-30
- Last Posted Date
- 2014-07-31
- Lead Sponsor
- Eye Therapies, LLC
- Target Recruit Count
- 57
- Registration Number
- NCT01675609
- Locations
- 🇺🇸
Ora, Inc., Andover, Massachusetts, United States
A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)
Phase 2
Completed
- Conditions
- Allergic Conjunctivitis
- Interventions
- First Posted Date
- 2011-01-12
- Last Posted Date
- 2012-03-06
- Lead Sponsor
- Eye Therapies, LLC
- Target Recruit Count
- 68
- Registration Number
- NCT01275105
- Locations
- 🇺🇸
Ora, Inc., Andover, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath